We are live on ! Find out more
SCA

Strategic Capital Alternatives Portfolio holdings

AUM $6.3M
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$416M
AUM Growth
+$14.7M
Cap. Flow
+$15.8M
Cap. Flow %
3.8%
Top 10 Hldgs %
23.22%
Holding
468
New
186
Increased
74
Reduced
65
Closed
–

Top Buys

Rank Stock Value
1
RALS
ProShares RAFI Long/Short
RALS
+$2.41M
2
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$2.15M
3
GILD icon
Gilead Sciences
GILD
+$1.74M
4
LNKD
LinkedIn Corporation
LNKD
+$1.17M
5
SPHY icon
State Street SPDR Portfolio High Yield Bond ETF
SPHY
+$1.11M

Top Sells

Rank Stock Value
1
ETV
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
+$2.97M
2
PPG icon
PPG Industries
PPG
+$1.26M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.11M
4
BAX icon
Baxter International
BAX
+$733K
5
QAI icon
NYLI Hedge Multi-Strategy Tracker ETF
QAI
+$719K

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.65%
2 Healthcare 12.39%
3 Technology 11.73%
4 Industrials 9.22%
5 Consumer Discretionary 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWC icon
451
iShares MSCI Canada ETF
EWC
$6.91B
$11K ﹤0.01%
+415
New +$11.7K
FDS icon
452
Factset
FDS
$10.8B
$11K ﹤0.01%
+68
New +$11K
MYE icon
453
Myers Industries
MYE
$1.25B
$11K ﹤0.01%
+600
New +$10.6K
NCZ
454
Virtus Convertible & Income Fund II
NCZ
$298M
$11K ﹤0.01%
+360
New +$11.6K
NKTR icon
455
Nektar Therapeutics
NKTR
$2.55B
$11K ﹤0.01%
67
– –
PRGO icon
456
Perrigo
PRGO
$1.99B
$11K ﹤0.01%
+62
New +$11.8K
PRU icon
457
Prudential Financial
PRU
$41.5B
$11K ﹤0.01%
+120
New +$10.2K
STK
458
Columbia Seligman Premium Technology Growth Fund
STK
$928M
$11K ﹤0.01%
+600
New +$11.6K
WMB icon
459
Williams Companies
WMB
$90.7B
$11K ﹤0.01%
+200
New +$10.3K
CATM
460
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$11K ﹤0.01%
+300
New +$11.4K
POT
461
DELISTED
Potash Corp Of Saskatchewan
POT
$11K ﹤0.01%
+350
New +$11.2K
YHOO
462
DELISTED
Yahoo Inc
YHOO
$11K ﹤0.01%
250
– –
CLX icon
463
Clorox
CLX
$12.5B
$10K ﹤0.01%
+99
New +$10.7K
CWB icon
464
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.68B
$10K ﹤0.01%
+211
New +$10.2K
IEF icon
465
iShares 7-10 Year Treasury Bond ETF
IEF
$43B
$10K ﹤0.01%
+99
New +$10.5K
PAYX icon
466
Paychex
PAYX
$45B
$10K ﹤0.01%
+3,415
New +$167K
RPM icon
467
RPM International
RPM
$13.5B
$10K ﹤0.01%
+214
New +$10.5K
VBR icon
468
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.8B
$1K ﹤0.01%
+14
New +$1.54K
15 16 17 18
19

Similar funds

RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
TSU
TD Securities (USA) New York $11M AUM 2.35% 1-Year Est. Return
GFWEV
G.F.W. Energy VII Irving, Texas $1.49M AUM 89.53% 1-Year Est. Return
LCP
Lamond Capital Partners San Francisco, California $14.3M AUM 30.74% 1-Year Est. Return
HCM
Hirzel Capital Management Dallas, Texas $15.1M AUM 5.29% 1-Year Est. Return
PPF
PartnerRe Principal Finance Greenwich, Connecticut $15.5M AUM 13.01% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
USG2
Union Square GP 2004 New York $34.6M AUM

Strategic Capital Alternatives's Q2 2015 Portfolio in Review

As of Q2 2015, Strategic Capital Alternatives held 468 positions worth $416M, up 3.7% from $401M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Strategic Capital Alternatives deployed $15.8M of net new capital in Q2 2015, opening 186 new positions and adding to 74 existing holdings. Its largest new stake was ProShares RAFI Long/Short: 59,057 shares worth $2.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Eaton Vance Tax-Managed Buy-Write Opportunities Fund, an estimated $2.97M trimmed.

  • Strategic Capital Alternatives's largest Q2 2015 buy was ProShares RAFI Long/Short: 59,057 shares worth $2.4M.
  • Strategic Capital Alternatives added most to Gilead Sciences in Q2 2015, an estimated $1.74M increase.
  • Strategic Capital Alternatives's biggest Q2 2015 reduction was Eaton Vance Tax-Managed Buy-Write Opportunities Fund, cutting an estimated $2.97M.
  • Strategic Capital Alternatives's ten largest holdings make up 23% of its $416M portfolio in Q2 2015.
  • Strategic Capital Alternatives opened 186 new positions and closed 0 in Q2 2015.
  • Strategic Capital Alternatives's portfolio value rose 3.7% quarter-over-quarter to $416M.

Based on Strategic Capital Alternatives's 13F filing for Q2 2015, filed 3 Aug 2015.